Join to access to all OVN content. Join for Free
How to Transition from MSL to MSL Leader
MSL to leadership personal development for managers effective time management strategies career advancement tips mentorship significance

How to Transition from MSL to MSL Leader


Share This Article


Summary

In this episode, Kathy Gann joins to discuss the transition from an MSL role to leadership positions. Kathy delves into personal development, goal setting, and the importance of lifelong learning and skill-building for aspiring managers. She shares insights on identifying the right time to step into management and the challenges that accompany such a transition. Kathy emphasizes effective time management, proactivity in career advancement, and the significance of mentorship. She also highlights strategies for gaining visibility through problem-solving and crafting a strategic leadership plan. The episode concludes with Kathy offering closing thoughts and acknowledgments.

Kathy Gann, Former Field MSL Director and MSL discusses how to transition from MSL to MSL Leader.

Kathy shares….

👉 How to position yourself for promotion

👉 What skills are mandatory and how to develop them

👉 How to prepare for a role in management

👉 The demands of being and MSL leader and what to expect

👉 The emotional side of being in charge of people

Click for Source
MSL to leadership, personal development for managers, effective time management strategies, career advancement tips, mentorship significance

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Promotability: Top 10 Tips for Landing Your Next Promotion
Partner Avatar MSL Talk: Tom Caravela, Bridget Rasmusson

Promotability: Top 10 Tips for Landing Your Next Promotion

Podcast
Diversity in Medical Affairs and the Power of Networking
Partner Avatar MSL Talk: Tom Caravela, Rachel Kennedy, Lashondra Taylor, Nirav Shah

Diversity in Medical Affairs and the Power of Networking

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN